# An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)

> **NCT00683462** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 24 (estimated)

## Conditions studied

- ADHD

## Interventions

- **DRUG:** Placebo
- **DRUG:** AZD3480
- **DRUG:** AZD3480

## Key facts

- **NCT ID:** NCT00683462
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** —
- **Final completion:** 2009-07
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2009-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00683462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00683462, "An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00683462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*